A simple process enables to synthesize tungsten oxide with various nanomorphologies, i.e. nanorods, nanowires, and nanosheets. The tungsten hexachloride (WCl 6 ) was used as a raw material and the tungsten oxide nanoparticles were obtained by solvothermal treatment with solvents, i.e., ethanol, mixed solvent (ethanol+water), and water, at 200°C for 10 h. The various crystalline phases of tungsten oxide, such as monoclinic W 18 O 49 nanorods, hexagonal WO 3 platelets, and monoclinic WO 3 nanosheets, were synthesized by simply changing the composition of the solvent. The oxygen, which was contained in water, played an important role in the final tungsten oxide phase. Especially, W 18 O 49 nanorods grew to nanowires as the concentration of WCl 6 was decreased. Using this simple process, it will be possible to control the crystalline phase and morphologies of nanostructured tungsten oxide system.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2005) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: